Fundraising Fox
Supernus Pharmaceuticals
Rockville, US · Founded 2005 · 857 employees on LinkedIn · 2 known investors
Find your way into Supernus Pharmaceuticals
Sign up to see every warm intro you have to Supernus Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Supernus Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Supernus is a pharmaceutical company that develops and markets products in the biosciences and pharmaceutical industry. This page lists awards and recognitions the company has received for growth, workplace, and performance.
Founders & leadership
Supernus Pharmaceuticals was founded in 2005 by Jack A. Khattar.
JA
Jack A. KhattarFounder
PB
Paolo Baroldi, M.D., Ph.D.Executive
TT
Tami T. Martin, R.N., Esq.Executive
Board
MB
Michael B. Sheffery, Ph.D.Board director
CW
Charles W. Newhall, IIIBoard director
MJ
M. James Barrett, Ph.D.Board director
JM
John M. SiebertBoard director
MB
Michael BighamBoard director
WA
William A. NuergeBoard director
FM
Frederick M. HudsonBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$30M disclosed across 1 round · 2011
▶$30MraisedFeb 2012 · 3 investors · PharmaceuticalsRule 506(b)
▶$30MraisedFeb 2012 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John M. SiebertDirector
- Michael BighamDirector
- William A. NuergeDirector
- Michael B. Sheffery, Ph.D.Director
- Padmanabh P. Bhatt, Ph.D.Executive Officer
- Charles W. Newhall, IIIDirector
- M. James Barrett, Ph.D.Director
- Paolo Baroldi, M.D., Ph.D.Executive Officer
- Frederick M. HudsonDirector
- Jack A. KhattarExecutive Officer, Director
- Tami T. Martin, R.N., Esq.Executive Officer
- Russell P. WilsonExecutive Officer
- Jones W. Bryan, Ph.D.Executive Officer
- Offering amount
- $30M
- Amount sold
- $30M
- Minimum investment
- $2M
- First sale
- Jan 2011
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Supernus Pharmaceuticals do?
- Supernus is a pharmaceutical company that develops and markets products in the biosciences and pharmaceutical industry. This page lists awards and recognitions the company has received for growth, workplace, and performance.
- Who founded Supernus Pharmaceuticals?
- Supernus Pharmaceuticals was founded by Jack A. Khattar in 2005.
- Who are Supernus Pharmaceuticals's investors?
- Supernus Pharmaceuticals's investors include MESA VERDE VENTURE PARTNERS, New Enterprise Associates (NEA).
- How much funding has Supernus Pharmaceuticals raised?
- Supernus Pharmaceuticals has disclosed $30M raised across 1 round.
- Where is Supernus Pharmaceuticals headquartered?
- Supernus Pharmaceuticals is headquartered in Rockville, US.